Press release from PR Newswire
Hologic Announces Appointment of New Director
Thursday, November 03, 2011
Hologic Announces Appointment of New Director16:01 EDT Thursday, November 03, 2011BEDFORD, Mass., Nov. 3, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that it has appointed Christiana Stamoulis to the Company's newly expanded Board of Directors. Ms. Stamoulis will serve on the Company's Corporate Development Committee.Ms. Stamoulis currently serves as Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals Incorporated, a developer of innovative therapies intended to improve the lives of people with serious diseases."Hologic is leading the way in women's health with a broad portfolio of best-in-class products that provides a strong foundation for future growth," said Ms. Stamoulis. "I am excited to be joining the Board and look forward to contributing to the Company's continued success." Ms. Stamoulis joined Vertex in 2009 with approximately 15 years of experience in the financial services and management consulting industries where she advised global pharmaceutical and biotechnology companies on strategic and corporate finance decisions. Prior to joining Vertex, she was a Managing Director in the Investment Banking division of Citigroup where she led the building of the firm's U.S. Life Sciences investment banking practice. Prior to her role at Citigroup, she was at Goldman, Sachs & Co. where she spent the majority of her investment banking career. Ms. Stamoulis started her career as a strategy consultant at The Boston Consulting Group. Ms. Stamoulis holds a Bachelor of Science degree in Economics and a Bachelor of Science degree in Architecture from the Massachusetts Institute of Technology (MIT). Additionally, she holds a Master of Business Administration from the MIT Sloan School of Management where she focused on Applied Economics and Finance. "We are extremely pleased to have Christiana on the Board," said David LaVance, Jr., Chairman of the Board of Hologic. "Her solid foundation in strategic development coupled with extensive experience in executing initiatives for growth will serve Hologic's Board well as the Company continues to grow."About Hologic, Inc.:Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. Hologic and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.Contact: Deborah R. Gordon Vice President, Investor RelationsHologic, Inc.(781) 999-7716SOURCE Hologic, Inc.